Clinical trial for Type 1 Diabetes
Official title Can Mindfulness and Virtual Reality Reduce Stress in Young Adults With Type 1 Diabetes?
ClinicalTrials.gov ID: NCT07793097
What this study is testing
- What it's testing
- The goal of this study is to learn if Mindfulness-Based Stress Reduction (MBSR) can be delivered using virtual reality (VR) technology to emerging adults (youth 16-20 years old) with type 1 diabetes and high levels of stress reactivity.
- Time commitment: about 8 weeks
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 20
You may be able to join if
- Age 16 to 20 years, inclusive
- Diagnosed with type 1 diabetes (T1D) for at least six months
- Have elevated levels of stress reactivity as assessed by the Perceived Stress Reactivity Scale (PSRS)
- Access to an internet-enabled device on which the participant can participate in virtual study activities
You likely can't join if
- Significant co-morbid mental health problems limiting the participant's ability to engage effectively in the group nature of the intervention (i.e...
- Co-morbid physical health problems in which diabetes is secondary to another chronic medical illness (e.g., cystic fibrosis) and their medical...
- Non-English fluency
The study team makes the final eligibility decision.
Where it is enrolling
- Baltimore, Maryland, United States
- Detroit, Michigan, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 8 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 20 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Baltimore, Maryland, United States; Detroit, Michigan, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.